P-338 TSPO is a novel molecular target for noninvasive detection of endometriosis
Abstract Study question Is TSPO expressed in endometriotic lesions and negative in adjacent tissues, being eligible as a molecular target for noninvasive detection of endometriosis? Summary answer TSPO is detected in endometriotic lesions and its presence is mostly negative in adjacent tissue. TSPO-...
Gespeichert in:
Veröffentlicht in: | Human reproduction (Oxford) 2022-06, Vol.37 (Supplement_1) |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract
Study question
Is TSPO expressed in endometriotic lesions and negative in adjacent tissues, being eligible as a molecular target for noninvasive detection of endometriosis?
Summary answer
TSPO is detected in endometriotic lesions and its presence is mostly negative in adjacent tissue. TSPO-based molecular imaging is potentially feasible for noninvasive endometriosis detection.
What is known already
TSPO is a 18KDa protein located in the outer mitochondrial membrane, mostly in neurons, but also in inflammatory sites outside the brain. There are specific TSPO ligands - such as PBRR111 and PK11195 - that can be conjugated to radioisotopes to allow non-invasive imaging of tissues rich in TSPO, using positron emission tomography (PET). Studies have shown that TSPO is present in the rat uterus, therefore we hypothesized that it might also be expressed in the human endometrial-like tissue, being a target for molecular imaging of endometriosis.
Study design, size, duration
Prospective cross-sectional study including women with endometriosis (n = 24) and endometriosis-free controls (n = 12). All participants were enrolled in this study from March 2017 to September 2018 and signed an informed consent approved by the IRB.
Participants/materials, setting, methods
Endometriosis lesions (n = 83) and endometrium from endometriosis patients (n = 28) were obtained during laparoscopy, while endometrial samples from control women (n = 12) were collected by Pipelle® at hysteroscopy examination. TSPO mRNA expression was evaluated by quantitative reverse-transcription real time PCR (RT-PCR) in samples of endometrium and lesions, while TSPO protein expression was evaluated by immunohistochemistry (IHC) with a monoclonal antibody anti-human TSPO.
Main results and the role of chance
TSPO mRNA was detected in endometrium from control women and from endometriosis patients, as well as in endometriotic lesions. The RT-PCR results were homogeneous for amplification of the S26 reference gene. The duplicates of the samples were concordant and the melting curves (Tm) showed a single peak for TSPO and S26 genes, demonstrating the reliability of the results. TSPO protein was localized in endometrium and in several types of endometriotic lesions. The immunostaining index (on a 0 to 6 scale) was higher in the glandular epithelium (median 4.5, interquartile range 4 to 5) than in the stroma (median 2, interquartile range 2 to 3, p |
---|---|
ISSN: | 0268-1161 1460-2350 |
DOI: | 10.1093/humrep/deac107.322 |